ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
SoftBank

SoftBank sets up subsidiary for COVID-19 testing

Tech investor aims to offer 'low cost and high frequency' saliva PCR tests

SoftBank Group is establishing a subsidiary to offer saliva-based coronavirus tests. (Source photos by Takaki Kashiwabara and Ken Kobayashi)

TOKYO -- SoftBank Group on Wednesday said it established a subsidiary to offer saliva-based coronavirus tests, as Japan continues to grapple with the spread of COVID-19.

The new company, Coronavirus Inspection Center Corp., aims to offer "low cost and high frequency" saliva-based polymerase chain reaction tests, SoftBank said. With the cooperation of the National Center for Global Health and Medicine, it will begin testing employees as well as its baseball team players.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more